Karl Hsu
- Co-authors
- Robert A. BeckmanYan LiJan H.M. SchellensGilles TuffalMarlies H.G. LangenbergMaja J.A. de JongeSandrine MacéVincent A. de Weger
- Topics
- Monoclonal and Polyclonal Antibodies Research (3 papers)Cancer Research and Treatments (2 papers)Cancer, Hypoxia, and Metabolism (2 papers)
- Cited by
- HematologyOncologyCancer Research
- Partner nations
- United StatesFranceGermany
In The Last Decade
Karl Hsu
13 papers receiving 426 citations
Peers
Comparison fields: 5 of 59
- Molecular Biology 255
- Oncology 168
- Hematology 101
- Cancer Research 82
- Pulmonary and Respiratory Medicine 80
Countries citing papers authored by Karl Hsu
This map shows the geographic impact of Karl Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Hsu more than expected).
Fields of papers citing papers by Karl Hsu
This network shows the impact of papers produced by Karl Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Hsu. The network helps show where Karl Hsu may publish in the future.
Co-authorship network of co-authors of Karl Hsu
This figure shows the co-authorship network connecting the top 25 collaborators of Karl Hsu. A scholar is included among the top collaborators of Karl Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Hsu. Karl Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 1 | |
| 4 | 46 | |
| 5 | 3 | |
| 6 | 105 | |
| 7 | 27 | |
| 8 | 2 | |
| 9 | 1 | |
| 10 | 8 | |
| 11 | 2 | |
| 12 | 57 | |
| 13 | 39 | |
| 14 | 136 |
About Karl Hsu
Karl Hsu is a scholar working on Oncology, Biotechnology and Hematology, having authored 14 papers that have together received 433 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer Research and Treatments (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Hematology (101 citations), Oncology (168 citations) and Cancer Research (82 citations). Karl Hsu has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Robert A. Beckman, Yan Li, Jan H.M. Schellens, Gilles Tuffal, Marlies H.G. Langenberg, Maja J.A. de Jonge, Sandrine Macé, Vincent A. de Weger, Jaroslav Jelı́nek and Ting Xi Liu. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.